Welcome and opening

CLOSE

Session 1

• Explain the potential and limitations of machine learning and cheminformatics for drug induced liver injury.
• Name at least one advantage and one disadvantage of in vitro research as predictor of the clinical toxicity of NPS.
• To understand how experimental animal models are designed and to which level they contribute to understand toxicity in humans.

CLOSE

Rest break

CLOSE

Session 2

• Describe the opportunities and the limits of pharmacogenomics in patient care.
• Know how metabolomic approaches could be useful to tackle the impact of toxicant such as acute dioxin exposure on human metabolism.
• Learn the interest of different methods of pharmacokinetics analysis and how to relate PK to the markers of intoxication (pharmacodynamic) to better understand the possible mechanisms involved.

CLOSE

Lunch break

CLOSE

Session 3

• Explain the benefit but also the limitations of in vitro cell culture models for predicting acute drug toxicity.
• Describe how xenobiotics disrupt mitocondrial metabolic pathways and the methods of investigation for these.
• Overview of the different models of organ on chips and organoids used to identify toxicity mechanism: from the clinical case to the cell biology laboratory.

CLOSE

Rest break

CLOSE

Session 4

• Outline how PET imaging and specific biomarkers may be utilised to study kinetics and interactions in the CNS.
• Outline the basis of neuroelectrophysiological tests that assess peripheral nerves, neuromuscular junctional transmission and the central nervous system in organophosphate poisoning.
• Describe the strengths and weaknesses of manipulation of large data sets for meaningful research in toxicology.

CLOSE

End of Precongress symposium 2021

CLOSE

WELCOME AND OPENING / INTRODUCTION TO THE CONFERENCE PLATFORM

CLOSE

CAUSTIC INGESTION SYMPOSIUM

• Describe factors influencing outcome of caustic ingestions regarding patterns of exposure, characteristics of agent involved and age of exposed patients.
• Outline the potential benefits of CT in the emergency management of caustic injuries and discuss the optimal use of endoscopy in the emergency management of caustic injuries in children.
• Explain the main points of the pathophysiology of caustic injuries and describe the management in acute situations and in the follow up.

CLOSE

Rest break and AUTHORS WITH POSTERS (Morning grouping)

CLOSE

ORAL PLATFORM AND SHORT ORAL PRESENTATIONS

CLOSE

AUTHORS WITH POSTERS (Lunchtime grouping)

CLOSE

ALCOHOL AS A CO-INGESTANT IN THE POISONED PATIENT

• Discuss mechanistically how alcohol complicates management of stimulant drug ingestion and provide specific examples.
• Describe the effect of ethanol when co-ingested with CNS-depressants in regard to symptoms, clinical management and outcome.
• Explain how blood alcohol concentration interacts with insecticide dosing to worsen outcome in OP insecticide poisoning.
• Listing clinically relevant studies of the effect(s) of alcohol on paracetamol toxicity, explain the possible protective mechanism of alcohol and debate the pros and cons of alcoholuse in the treatment of paracetamol poisoning.
• Describe how ethanol can be used to treat methanol and ethylene glycol poisonings .

CLOSE

Rest break and AUTHORS WITH POSTERS (Afternoon grouping)

CLOSE

FELLOWS LECTURE

• Understand the exposures contained in current electronic vaping products in common use.
• Understand the Acura effects of vaping aerosol exposure on the henna lung.
• Understand the clinical syndromes associated with vaping.
• Understand management and prevention interventions in EVALI. 7

CLOSE

UPDATE FROM THE GUIDELINES COLLABORATIVE GROUP

CLOSE

END OF DAY 1

CLOSE

WELCOME DAY 2 / RE-INTRODUCTION TO THE CONFERENCE PLATFORM

CLOSE

APAMT SYMPOSIUM: TOXICOVIGILANCE DURING COVID-19 IN THE ASIAN-PACIFIC REGION

• Learn about significant toxic exposures during COVID-19 pandemic in Asia -Pacific area.
• Understand key steps of toxicovigilance taken in an Asian Pacific context
• Apply lessons learned about the signal identification, data gathering, risk assessment and responses measures to their local context.

CLOSE

Rest break and AUTHORS WITH POSTERS (Morning grouping)

CLOSE

ORAL PLATFORM AND SHORT ORAL PRESENTATIONS

CLOSE

FELLOWS MEETING

CLOSE

AUTHORS WITH POSTERS (Lunchtime grouping)

CLOSE

YOUNG INVESTIGATORS AWARD

CLOSE

COVID-19 SYMPOSIUM

• Describe the effect of pandemic waves on Europe Health System and how the EAPCCT working-group is investigating the influence of the COVID-19 pandemic on the work of European Poison Control Centres (PCCs).
• Describe the process of expanding the role of a regional poison center to provide a 24/7 public health hotline in response to the COVID-19 pandemic, as an information service as well as a critical component of surveillance and response.
• Describe the opportunities for virtual toxicology education and networking during a pandemic.

CLOSE

Rest break and AUTHORS WITH POSTERS (Afternoon grouping)

CLOSE

COVID-19 SYMPOSIUM

• List the repurposed and new drugs used in the context of COVID19 and outline the available clinical data regarding their efficacy and safety for COVID19 prophylaxis and treatment
• Describe the mechanism of toxicity and treatment of patients exposed to sodium chlorite.
• To learn about the impact of COVID-19 on recreational drugs in Europe (including on market, use, harm and treatment) based on a 'Trendspotter analysis' of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

CLOSE

END OF DAY 2

CLOSE

DRUG FORMULATION AND ITS IMPORTANCE IN THE POISONED PATIENT

• Explain the pharmacokinetic and pharmacodynamic features of poisoning with various newer drug formulations that can influence the risk assessment and initial management of the poisoned patient.
• Identify known physicochemical properties of pharmaceutical preparations prone to cause pharmacobezoar formation - the formation and degradation.
• Describe ways to identify the formation of pharmacobezoars and possible treatment modalities in the poisoned patient where their formation is suspected or identified.
• Understand the frequency of and methods by which prescription medicines can be used by routes other than the intended licenced route(s) of use.

CLOSE

Rest break and Authors with posters (Morning grouping)

CLOSE

LOUIS ROCHE LECTURE

• understand the contribution of the proposed different therapies in cardiotoxicant poisonings

CLOSE

Authors with posters (Lunchtime grouping)

CLOSE

GENERAL ASSEMBLY

CLOSE

TOXICOLOGY 2.0 SYMPOSIUM

• Identify important poisoning trends.
• State the features of poisoning events in different age groups.
• Describe the importance and challenges of poison prevention education.
• List two effective strategies for delivering poison prevention knowledge to children.
• Describe various modern artificial intelligence techniques, applicable in different scenarios and types of data (tabular data, images, text), as well as determine and decide which particular problems are suitable for application of AI techniques.
• Explain the role of online drug information forums in both reflecting and driving patterns of drug use, and their utility and limitations in studying these patterns.
• Describe tools in Google and Twitter that can help characterize novel psychoactive substance trends.
• Explain the basic concepts behind using wastewater epidemiology to measure populationlevel exposure and consumption of opioids, cocaine, NPS and methamphetamines and describe results from a pilot study applying wastewater epidemiology to map opioid consumption in a US municipality
• Understand the appropriate use of data derived from various types of social media.
• Understand the current state of art in ingestible electronics and the principles of biosensing in drug testing.
• Describe current use of telemedicine and other emerging technologies in the setting of chemical weapon attacks.

CLOSE

Rest break and Authors with posters (Afternoon grouping)

CLOSE

END OF DAY 3, END OF EAPCCT 2021 VIRTUAL CONFERENCE

CLOSE

ORAL PLATFORM AND SHORT ORAL PRESENTATIONS

CLOSE

WELCOME DAY 3 / RE-INTRODUCTION TO THE CONFERENCE PLATFORM

CLOSE

REST BREAK / AUTHORS WITH POSTERS (MORNING GROUPING)

• Morning Posters - Room 01
  116  Massive gamma-hydroxybutyric acid overdose resulting in severe metabolic acidosis requiring continuous venovenous haemofiltration
  Anselm Wong, Victorian Poisons Information Centre, Austin Toxicology and Emergency Department, Austin Health, Victoria, Australia.
  Drugs of abuse and NPS poisoning
  
  138  Just “https://eapcct2021.com/administrator/index.php#wf-editor-sourcenanging” around: case series of neurological sequelae from chronic nitrous oxide abuse
  Angela L Chiew, Clinical Toxicology Unit, Prince of Wales Hospital, Sydney, Australia.
  Drugs of abuse and NPS poisoning
  
  197  Analytically-confirmed exposure to new psychoactive substances in patients with severe clinical toxicity in the UK, 2015-2018: a report from the IONA study
  Simon H Thomas, Narional Poisons Information Service, Newcastle Hospitals NHS Foundation Trust, Newcastle, United Kingdom.
  Drugs of abuse and NPS poisoning
  
  198  Increasing abuse and addiction to nitrous oxide (N2O): still a legal high in Denmark
  Lotte CG Hoegberg, Department of Anaesthesiology, The Danish Poisons Information Centre, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark.
  Drugs of abuse and NPS poisoning
  
  309  Severe cardiac and neurological toxic effects due to synthetic cannabinoid cumyl-pegaclone (SGT-151) alone: a case report
  Andrea Giampreti, Bergamo Poison Control Center, Bergamo Poison Control Center, Bergamo, Italy.
  Drugs of abuse and NPS poisoning
  
  310  Beta-hydroxybutyrate closed the gap in a sober patient with high anion gap metabolic acidosis: a case report
  Marian Piqueur, Department of Laboratory Medicine, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
  Drugs of abuse and NPS poisoning
  
  
• Morning Posters - Room 02
  117  Hyperemesis and acute kidney injury following a “rebirth” ceremony with kambô and iboga in the Netherlands
  Marian Piqueur, Laboratory Medicine, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
  Drugs of abuse and NPS poisoning
  
  126  Clinical effects following the use of freely available herbal drugs: the toxicity of “Happy Caps”
  Antoinette JHP Riel, Dutch Poisons Information Center(DPIC), Univesity Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
  Drugs of abuse and NPS poisoning
  
  131  Recreational nitrous oxide use rises dramatically after change in EU legislation
  Antoinette JHP Van Riel, Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht Univeristy, Utrecht, Netherlands.
  Drugs of abuse and NPS poisoning
  
  136  Treating patients with opioid overdose at a primary care emergency outpatient clinic: a cost-minimization analysis
  Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
  Drugs of abuse and NPS poisoning
  
  137  Self-discharge during treatment for acute recreational drug toxicity: an analysis of four-years of Euro-DEN Plus presentations
  Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
  Drugs of abuse and NPS poisoning
  
  150  Treatment with naloxone and follow up after opioid overdose outside of hospital: observational data 2014-2018 in Oslo, Norway
  Arne K Skulberg, Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway; Pre-hospital Division, Air Ambulance Department, Oslo University Hospital, Oslo, Norway ; The Norwegian Air Ambulance Foundation, Oslo, Norwa, Trondheim, Norway.
  Drugs of abuse and NPS poisoning
  
  158  Change of quality of life in prescription opioid patients after rapid opioid detoxification
  Gabija Laubner, Republican Vilnius University Hospital, Centre of Toxicology; Vilnius University Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  Drugs of abuse and NPS poisoning
  
  160  First identification of synthetic cannabinoid 5F-MDMB-PICA in Italy
  Carlo Alessandro Locatelli, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
  Drugs of abuse and NPS poisoning
  
  313  Poisoning by central stimulant drugs in Oslo, Norway
  Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
  Drugs of abuse and NPS poisoning
  
  314  Acute poisoning from concurrent use of opioids and amphetamine
  Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
  Drugs of abuse and NPS poisoning
  
  315  Acute recreational drug toxicity among young patients
  Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
  Drugs of abuse and NPS poisoning
  
  316  Acute poisonings involving cannabis in Oslo, Norway
  Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
  Drugs of abuse and NPS poisoning
  
  317  Psychosis associated with acute recreational drug toxicity
  Odd Martin Vallersnes, Department of General Practice, University of Oslo, Oslo, Norway.
  Drugs of abuse and NPS poisoning
• Morning Posters - Room 03
  007  The severity and mortality prediction of calcium-channel blocker poisoning in the intensive care unit
  Chun Kuei Chen, Emergency department, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.
  Pharmaceutical Poisoning
  
  201  Comparison of the Australian and New Zealand Referral Criteria versus the King’s College Criteria to predict mortality or liver transplant in paracetamol overdose
  Anselm Wong, Victorian Poisons Information Centre, Austin Toxicology Unit and Emergency Department, Austin Health, Victoria, Australia.
  Pharmaceutical Poisoning
  
  241  Angiotensin axis antagonists increase the severity of dihydropyridine poisoning
  Betty S Chan, Clinical Toxicology & Emergency Medicine, Prince of Wales Hospital, Sydney, Australia.
  Pharmaceutical Poisoning
  
  242  A case series of flecainide poisoning
  Betty S Chan, Clinical Toxicology & Emergency Medicine, Prince of Wales Hospital, Sydney, Australia.
  Pharmaceutical Poisoning
  
  243  Effect of serum alkalinisation on QRS narrowing in tricyclic antidepressant poisoning
  Betty S Chan, Clinical Toxicology & Emergency Medicine, Prince of Wales Hospital, Sydney, Australia.
  Pharmaceutical Poisoning
  
  244  Optimal way to achieve serum alkalinisation in tricyclic antidepressant overdose
  Betty S Chan, Clinical Toxicology & Emergency Medicine, Prince of Wales Hosptial, Sydney, Australia.
  Pharmaceutical Poisoning
  
  246  An uncommon cause of high-anion gap metabolic acidosis after repeated supratherapeutic paracetamol ingestion
  Hwee Min D Lee, Emergency, Monash Health, Melbourne, Australia.
  Pharmaceutical Poisoning
  
  262  Lurasidone mono-ingestion overdoses: a case series with minimal toxicity
  Andis Graudins, Clinical Toxicology Unit, Emergency Medicine Service, Monash Health and Monash University, Dandenong, Australia.
  Pharmaceutical Poisoning
  
  331  A 1-year prospective analysis of propranolol exposures reported to the UK National Poisons Information Service (NPIS)
  Pardeep S Jagpal, National Poisons Information Service (Birmingham Unit), Birmingham, United Kingdom.
  Pharmaceutical Poisoning
  
  332  Intravenous pentobarbital overdose treated with supportive care and multidose activated charcoal
  Rachel WC Ng, Clinical Pharmacology and Toxicology, Western Sydney Local Health District Toxicology Service, Westmead, Australia.
  Pharmaceutical Poisoning
  
  333  The impact of codeine upscheduling on prescriptions, overdoses, Emergency Department presentations and mortality in Victoria, Australia
  Anselm Wong, Victorian Poisons Information Centre and Austin Toxicology Unit, Austin Health, Victoria, Australia.
  Pharmaceutical Poisoning
• Morning Posters - Room 04
  196  Is fentanyl responsible for more severe neuro-respiratory depression than morphine? A rat in vivo investigation
  Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
  Mechanisms of Toxicity and Basic Research
  
  231  Sarolaner-poisoning in an infant: a case report
  Angelika Holzer, Poisons Information Centre Austria, Vienna, Austria.
  Pharmaceutical Poisoning
  
  252  Acute kidney failure due to acetaminophen overdose: a case report
  Marian Piqueur, Departement of Laboratory Medicine, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
  Pharmaceutical Poisoning
  
  253  Venlafaxine-associated hypoglycemia: frequency and correlation with symptom severity
  Elias Bekka, Department of Clinical Toxicology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
  Pharmaceutical Poisoning
  
  254  Hydroxyzine poisoning in the intensive care unit: predictive factors of cardiovascular complications and toxicokinetics
  Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
  Pharmaceutical Poisoning
  
  255  Lamotrigine poisoning in the ICU: a case series with evaluation of the toxicocokinetics and the predictive value of the plasma concentration on admission
  Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
  Pharmaceutical Poisoning
  
  256  Rispiridone poisoning in the intensive care unit: evaluation of the poisoning severity on admission
  Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
  Pharmaceutical Poisoning
  
  257  Nicardipine poisoning in the intensive care unit: management, outcome and toxicokinetics
  Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
  Pharmaceutical Poisoning
  
  258  Poisonings involving angiotensin-converting enzyme inhibitors in the intensive care unit: a case series
  Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
  Pharmaceutical Poisoning
  
  259  Salicylate poisoning admitted to the intensive care unit: features and toxicokinetics
  Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
  Pharmaceutical Poisoning
  
  260  Antidepressant drug poisonings and the risk of thromboembolic complications: a case series from an intensive care unit
  Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
  Pharmaceutical Poisoning
  
  263  Combined beta-blocker and beta-agonist drugs overdose: an unusual balance
  Andrea Giampreti, Bergamo Poison Control Center, Papa Giovanni XXIII Hospital, BERGAMO, Italy.
  Pharmaceutical Poisoning
  
  264  Characteristics of use and outcome of naloxone administration to non-intensive care and non-surgical hospitalized adult patients: a pilot study
  Ophir Lavon, Clinical Pharmacology and Toxicology Unit, Carmel Medical Center, Haifa, Israel.
  Pharmaceutical Poisoning
  
  266  Medication errors in nursing homes and other residential institutions with full-time staff attendance: a Danish Poisons Information Centre quality project
  Karen R Eriksen, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
  Pharmaceutical Poisoning
  
  268  Crisis averted? Olanzapine as an antidote for serotonin toxicity: a case report
  Erik Lindeman, Swedish Poisons Informatiom Center, Stockholm, Sweden.
  Pharmaceutical Poisoning
  
  269  Non-cardiogenic pulmonary edema in amlodipine poisoning: the lesser evil?
  Erik Lindeman, Swedish Poisons Information Center, Stockholm, Sweden.
  Pharmaceutical Poisoning
  
  271  Pharmacobezoar and gastric perforation in severe quetiapine intoxication: a case report
  Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
  Pharmaceutical Poisoning
  
  273  Intoxication with colchicine: a retrospective study
  Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
  Pharmaceutical Poisoning
  
  334  Intravenous iron overdose: don’t trust the blood levels
  Ann-Charlott Svanhagen, Swedish Poisons Information Center, Swedish Poisons Information Center, Stockholm, Sweden.
  Pharmaceutical Poisoning
• Morning Posters - Room 05
  011  Hydrofluoric acid exposure: a five-year review of enquiries made to the UK National Poisons Information Service (NPIS)
  Michael J Beech, NPIS (Birmingham Unit), City Hospital, Birmingham, United Kingdom.
  Epidemiology of poisoning
  
  012  Enquiries to the National Poisons Information Centre in Ireland from ambulance control, emergency medical dispatchers and paramedics attending poisoning incidents from 2010-2018
  Edel Duggan, National Poisons Information Centre, Beaumont Hospital, Dublin, Ireland.
  Epidemiology of poisoning
  
  014  109 toxicological inquiries for one patient
  Daniela Pelclova, Toxicological Information Centre, First Medical Faculty and General University Hospital, Prague, Czech Republic.
  Epidemiology of poisoning
  
  019  Eye injuries: case reports to the BfR from 2004 to 2018
  Kathrin Begemann, Department Exposure, Federal Institute for Risk Assessment (BfR), Berlin, Germany.
  Epidemiology of poisoning
  
  020  A worrying trend: Poisonings with pharmaceuticals in young girls in Norway
  Merethe Midtervoll, Norwegian Poison Information Centre, National Institute of Public Health, Oslo, Norway.
  Epidemiology of poisoning
  
  021  Study on e-liquids: risk of exposure and effectiveness of regulation by Tobacco Products Directive 2
  Nina Glaser, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
  Epidemiology of poisoning
  
  025  Mortality and patient characteristics in paracetamol overdosing: a retrospective study
  Soeren Boegevig, Department of Clinical Pharmacology, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
  Epidemiology of poisoning
  
  106  Assessment of advice given by the Danish Poisons Information Centre concerning medication errors in nursing homes and institutions
  Soeren Boegevig, Department of Clinical Pharmacology, The Danish Poisons Information Centre, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark.
  Epidemiology of poisoning
  
  108  Utilization of the Danish Poisons Information Centre: a nationwide registry study
  Tonny S Petersen, Department of Clinical Pharmacology, Bispebjerg Hospital, Copenhagen, Denmark.
  Miscellaneous
• Morning Posters - Room 06
  077  Beauty can occasionally be toxic: local irritation from a houseplant
  Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
  Plant and Mushroom Poisoning
  
  087  Kombucha tea: a potential hepatotoxic agent
  Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
  Plant and Mushroom Poisoning
  
  348  Veratrum Aqua poisonings resulting from its misuse: a case series from Moscow, Russia
  Elizaveta V Melnik, Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.
  Plant and Mushroom Poisoning
• Morning Posters - Room 07
  046  Unanticipated sources of methanol poisoning: report of two cases
  Jones CM Chan, Medicine & Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong.
  Household Products Poisoning
  
  049  Laundry pod exposure in children: evaluation of 17 years’ of cases in a tertiary care hospital in Italy
  Marcello Montibeller, Department of Emergency. Regional Paediatric Control Center., Bambino Gesù Children's Hospital, Rome, Italy.
  Household Products Poisoning
  
  351  Protective effects of hypercalcaemia in the setting of severe hypermagnesaemia
  David Emmerig, Western Sydney Local Health District Toxicology Service, Western Sydney Local Health District Toxicology Service, Westmead, Australia.
  Household Products Poisoning
  
  352  Caustic exposures attending the Emergency Department: results of the Spanish Toxic Surveillance System (STSS) 2010-2019
  Ana Ferrer-Dufol, Unit of Clinical Toxicology, Clinical University Hospital, Zaragoza, Spain.
  Household Products Poisoning
• Morning Posters - Room 08
  036  Assessment of the effectiveness of gastric lavage in organophosphorus poisoning by quantifying pesticide in lavage fluid
  Indira Madhavan, General Medicine, Associate Proferssor, Thrissur, India.
  Pesticide Poisoning
  
  042  Human exposures to pesticides: results of a subproject of the German pilot study PiMont
  Esther Feistkorn, German Federal Institute for Risk Assessment, Department Exposure, Unit Exposure Assessment of Hazardous Products, Berlin, Germany.
  Pesticide Poisoning
  
  358  Hepatorenal dysfunction following fipronil ingestion
  Indira Madhavan, Government Medical College, Thrissur, India.
  Pesticide Poisoning
  
  359  Malathion poisoning causing prolonged cholinergic crisis and refractory hypotension requiring high-dose atropine treatment
  Kit Rowe, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  (only available on May 27^th)
  Pesticide Poisoning
• Morning Posters - Room 09
  002  A watchful foretaste of Article 45 Annex VIII: things you will wish you knew before
  Geert Verstegen, Belgian Poison Centre, Brussels, Belgium.
  Miscellaneous
  
  003  Current experience of the Belgian Poison Centre with the new product notification requirements implementing article 45
  Anne-Marie K Descamps, Belgian Poison Centre, Brussels, Belgium.
  Miscellaneous
  
  179  Human skin explants ex vivo study: lesions caused by topical exposure to 25% tetramethylammonium hydroxide (TMAH)
  Alan H Hall, Medical Toxicology, Toxicology Consulting and Medical Translating Services, Azle, Texas, United States.
  Miscellaneous
  
  190  Risk assessment and lessons learned: a collaboration between Public Health and a National Poisons Information Centre
  Edel Duggan, National Poisons Information Centre, Dublin, Ireland.
  Miscellaneous
  
  204  Bedside formate analysis in methanol poisoned patients: a pilot study
  Knut Erik Hovda, The National CBRNE Centre of Medicine, Department of Acute Medicine, Oslo University Hospital, Oslo, Norway.
  Analytical and Forensic Toxicology - including bedside testing
  
  205  Bedside quantitative electroencephalographic monitoring using the Patient State Index correlates poorly with Glasgow Coma Score in acutely poisoned patients
  Shaun L Greene, Victoria Poisons Information Centre, Austin health, Melbourne, Australia.
  Pharmaceutical Poisoning
  
  207  A one-year retrospective study of caustic injury in adults admitted to a toxicology department
  Julia V Radenkova-Saeva, Clinic of Toxicology, UMHATEM "N.I.Pirogov", Sofia, Bulgaria.
  Caustic ingestion
  
  210  False positive result on colorimetric methanol screening test: report of two cases with hyperglycaemia
  Jones CM Chan, Medicine and Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong.
  Analytical and Forensic Toxicology - including bedside testing
• Morning Posters - Room 10
  057  Alcohol "abuse" among children younger 5 years
  Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
  Paediatric Poisoning
  
  060  Overrepresentation of flavoured, orodispersible tablets in paediatric paracetamol overdoses
  Johanna Nordmark Grass, Swedish Poisons Information Centre, Stockholm, Sweden.
  Paediatric Poisoning
  
  061  Drug-induced liver injury induced by nicotinamide
  Maren Hermanns-Clausen, Poisons Information Centre, Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, Medical Center – University of Freiburg, Freiburg, Germany.
  Paediatric Poisoning
  
  064  Pediatric and adolescent self-poisoning: a 3-year case series
  Carlo Alessandro Locatelli, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
  Paediatric Poisoning
  
  202  Three years of experience implementing a chemical submission protocol at an Emergency Department
  Juan Ortega Pérez, Emergengy Department Hospital Universitari Son Espases, Attending Physician, Palma de Mallorca, Spain.
  Miscellaneous
  
  367  The importance of free digoxin serum concentrations: case report of an infant treated for digoxin poisoning
  Marco Marano, Pediatric Intensive Care Unit; Pediatric Poison Control Center, Children's Hospital Bambino Gesù, Rome, Italy.
  Paediatric Poisoning
  
  368  Fentanyl transdermal patch mistaken for wound patch: two pediatric case reports
  Anna Celentano, Milan Poison Control Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  Paediatric Poisoning
  
  369  Bottles and messages revisited: circumstances of poisonings among infants under 1 year old in Estonia
  Ruth Kastanje, Poisonings Information Centre, Estonian Health Board, Tallinn, Estonia.
  Paediatric Poisoning
  
  370  Alcohol abuse among teenagers during the vacation period: description and pattern differences by gender
  Juan Ortega Pérez, Adult emergency department. Toxicology Unit, Attending physician, Palma de Mallorca, Spain.
  Paediatric Poisoning
  
  372  Paediatric paracetamol overdose: reducing side-effects with the SNAP 12 hour N-acetylcysteine regime
  David G Cairney, Acute Receiving Unit, Royal Hospital for Sick Children, Edinburgh, United Kingdom.
  Paediatric Poisoning
• Morning Posters - Room 11
  195  Antidote treatment in viper envenomation in Italy: a comparison of 4 antivenoms during a 6 year study
  Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
  Toxinology (bites, stings, antivenom etc)
  
  278  The changing pattern of treatment for latrodectism over time in a toxicology unit: red-back spider antivenom or standard analgesic therapy: nothing to RAVE about
  Andis Graudins, Clinical Toxicology Unit, Emergency Medicine Service, Monash Health and Monash University, Dandenong, Australia.
  Toxinology (bites, stings, antivenom etc)
  
  280  A serious viper bite in a pregnancy
  Francesco Gambassi, Toxicology Unit and Poison Control Center, Firenze, Italy.
  Toxinology (bites, stings, antivenom etc)
  
  281  Spider bites in France: a retrospective study using the French Poison Control Centers Network from 2007 to 2017
  Gaël Le Roux, Centre antipoison et Toxicovigilance Grand Ouest, Centre antipoison et Toxicovigilance Grand Ouest, Angers, France.
  Toxinology (bites, stings, antivenom etc)
  
  283  Recurrent thrombocytopenia after Italian viper bite: a case report
  Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy, Pavia, Italy.
  Toxinology (bites, stings, antivenom etc)
  
  377  Hyperbaric oxygen therapy in Loxoscelism skin necrosis: a case report
  Anna Celentano, Milan Poison Control Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  Toxinology (bites, stings, antivenom etc)
  
  378  Exotic venomous snakebites in Switzerland reported to the National Poisons Information Centre over 22 years
  Joan Fuchs, Tox Info Suisse, University of Zurich, Zurich, Switzerland.
  Toxinology (bites, stings, antivenom etc)
  
  379  Far from home: compartmental syndrome after envenomation by Crotalus atrox in metropolitan France
  Gaël Le Roux, Poison Control Center and Toxicovigilance, Angers, France.
  Toxinology (bites, stings, antivenom etc)
  
  380  Human exposure to larvae of processionary moths in France: study of symptomatic cases registered by the French Poison Control Centres between 2012 and 2019
  Sandra Sinno-Tellier, Health Alerts and Vigilance Department, French Agency for Food, environmental and Occupational Health & Safety, Maisons-Alfort, France.
  Toxinology (bites, stings, antivenom etc)

CLOSE

AUTHORS WITH POSTERS (LUNCHTIME GROUPING)

• Lunchtime Posters - Room 01
  119  3,4-Methylenedioxy-α-pyrrolidinohexiophenone (MDPHP): four severe confirmed intoxicationsn
  Dieter Müller, Clinical Toxicology Laboratory, GIZ-Nord Poisons Centre, University Medical Center Göttingen, Georg-August-University, Göttingen, Germany.
  Drugs of abuse and NPS poisoning
  
  143 Methadone poisonings admitted to the ICU: investigation of the predictive value of plasma methadone concentration and the required naloxone dose regimen
  Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
  Drugs of abuse and NPS poisoning
  
  147  Severe acidosis and prolonged coma after a massive overdose of gamma-hydroxybutyrate (GHB)
  Johanna Nordmark Grass, Swedish Poisons Information Centre, Stockholm, Sweden.
  Drugs of abuse and NPS poisoning
  
  155  The development of poisonings with illegal substances: data from the Danish Poisons Information Centre (DPIC)
  Dorte F Palmqvist, Department of Anaesthesiology, The Danish Poisons Information Centre, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark.
  Drugs of abuse and NPS poisoning
  
  318  E-liquid sold as CBD e-liquid containing XRL-11: 4 cases reported. A warning signal to health authorities and e-cigarettes users
  Francis Grossenbacher, University Hospital Reims, Clinical Toxicologist Emergency Department, Reims, France.
  Drugs of abuse and NPS poisoning
  
  319  Significant cannabidiol (CBD) urine concentration in a young male admitted after using an e-cigarette obtained from a street market
  Francis Grossenbacher, University Hospital Reims, Clinical Toxicologist Emergency Department, Reims, France.
  Drugs of abuse and NPS poisoning
  
  320  Swedes like their O-juice from Florida and their E-juice from California
  Sonny Larsson, Swedish Poisons Information Center, Swedish Poisons Information Center, Stockholm, Sweden.
  Drugs of abuse and NPS poisoning
  
  321  Hydroxyphencyclidines (OH-PCPs), fluoroamphetamine (FA) and fluoromethamphetamine (FMA): an explosive NPS mixture and a challenge for appropriate sedation in a severely intoxicated patient patient.
  Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
  Drugs of abuse and NPS poisoning
  
  322  Recreational, inhalational misuse of hyoscine butylbromide (Buscopan®) tablets as reported to the UK National Poisons Information Service
  Emma J Moyns, National Poisons Information Service (Birmingham Unit), Birmingham, United Kingdom.
  Drugs of abuse and NPS poisoning
  
  323  A case of crack-lung-like syndrome due to new synthetic opioid consumption with analytical confirmation
  Azzurra Schicchi, Pavia Poison Control Centre - National Toxicology Information Centre – Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.
  Drugs of abuse and NPS poisoning
  
  
• Lunchtime Posters - Room 02
  124  In-patient prescription opioid detoxification: peculiarities of consumption and treatment outcomes
  Gabija Laubner, Vilnius University, Faculty of Medicine, Vilnius, Lithuania, Vilnius University Emergency hospital, Vilnius, Lithuania.
  Drugs of abuse and NPS poisoning
  
  125 In-patient prescription opioid detoxification: gender differences and harmful habits
  Gabija Laubner, Vilnius University, Faculty of Medicine, Vilnius, Lithuania, Vilnius University Emergency hospital, Vilnius, Lithuania.
  Drugs of abuse and NPS poisoning
  
  132  Analysis of drugs in blood and urine samples from suspected spiked drink victims
  Odd Martin Vallersnes, Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.
  Drugs of abuse and NPS poisoning
  
  142  Transient delayed brain edema after consumption of synthetic cathinones
  Sabrina Schmoll, Department for clinical toxicology and poision control centre munich, Klinikum rechts der Isar München, München, Germany.
  Drugs of abuse and NPS poisoning
  
  149   GHB overdose in nightlife settings and effectiveness of on-site harm-reduction organization
  Miran Brvar, Centre for Clinical Toxicology and Pharmacology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  Drugs of abuse and NPS poisoning
  
  152   Acute intoxication with α-pyrrolidinohexanophenone, 4-fluoromethylphenidate and aminopropylbenzofuran complicated with rhabdomyolysis: a case report
  Gambassi Francesco, Toxicology Unit and Poison Control Center, Careggi University Hospital, Florence, Italy.
  Drugs of abuse and NPS poisoning
  
  157  Characteristics of ecstasy toxicity in a Norwegian cohort of hospitalized poisoned patients
  Per Sverre Persett, Department of Acute Medicine, Oslo University Hospital, Oslo, Norway.
  Drugs of abuse and NPS poisoning
  
  324 A comparative analysis between acute ethanol poisoning and acute ethanol combined with drugs of abuse poisoning in adolescents
  Viorela Nitescu, Pediatric Poisoning Centre Emergency Clinical Hospital for Children "Grigore Alexandrescu", Bucharest, Romania.
  Drugs of abuse and NPS poisoning
  
  325  Predicting hypertension using subjective symptoms in recreational drug users at first-aid stations at dance events
  Yoram P Prins, Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht, Netherlands.
  Drugs of abuse and NPS poisoning
  
  
• Lunchtime Posters - Room 03
  335   Favorable acute toxicity profile of the “hiking” stimulant nikethamide
  Colette Degrandi, National Poisons Information Centre, Tox Info Suisse, Associated Institute of the University of Zurich, Zurich, Switzerland.
  Pharmaceutical Poisoning
  
  336 Successful 40-hour delayed acetylcysteine treatment in a severe acetaminophen acute hepatitis
  Andrea Giampreti, Bergamo Poison Control Center, Bergamo Poison Control Center, Bergamo, Italy.
  Pharmaceutical Poisoning
  
  337  “Reversal” of dabigatran-induced anticoagulation with idarucizumab: experience of an Italian hospital
  Andrea Giampreti, Bergamo Poison Control Center, Bergamo Poison Control Center, Bergamo, Italy.
  Pharmaceutical Poisoning
  
  338  Metformin-related enquiries from hospitals to the National Poisons Information Service (NPIS) between 2010-2019: a comparison of metformin only and polypharmacy exposures
  Bethan W Hughes, National Poisons Information Service, Cardiff, United Kingdom.
  Pharmaceutical Poisoning
  
  339  Characteristics of emergency department presentations following a drug suicide attempt
  Mirjam Kummer, Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  Pharmaceutical Poisoning
  
  340  Propylthiouracil administration in 5 cases of thyroid hormone intoxication
  Francesca Maida, Pavia Poison Control Centre - National Toxicology Information Centre - Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
  Pharmaceutical Poisoning
  
  341  Evaluation of the overdosage section in Summaries of the Product Characteristics for medicines responsible for exposure calls to the Belgian Poison Centre
  Jonas Moens, Belgian Poison Control Centre, Neder-Over-Heembeek, Belgium.
  Pharmaceutical Poisoning
  
  342 Is haem arginate safer in overdose than previously thought? An uneventful four-fold accidental overdose
  Nandesh C Patel, National Poisons Information Service (Birmingham Unit), City Hospital, Birmingham, United Kingdom.
  Pharmaceutical Poisoning
  
  
• Lunchtime Posters - Room 04
  065  Animal PoisonLine: review of a new public access veterinary poisons information service
  Zoe Tizzard, Veterinary Poisons Information Service, London, United Kingdom.
  Veterinary toxicology (poisoning in animals)
  
  066 Flurbiprofen toxicosis in dogs
  Nicola Bates, Veterinary Poisons Information Service, London, United Kingdom.
  Veterinary toxicology (poisoning in animals)
  
  067  A retrospective study of cement exposure in 42 dogs
  Nicola Bates, Veterinary Poisons Information Service, London, United Kingdom.
  Veterinary toxicology (poisoning in animals)
  
  068  Cases of botulism in waterfowls in the Po river valley
  Carlo A. Locatelli, Pavia Poison Control Centre - National Toxicology Information Centre, Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
  Veterinary toxicology (poisoning in animals)
  
  383  Role of decontamination in dogs poisoned by alphachloralose-based rodenticides: a case series
  Marieke A Dijkman, Dutch Poisons Information Center (DPIC), University Medical Center Utrecht, Utrecht, Netherlands.
  Veterinary toxicology (poisoning in animals)
  
  384  “Curiosity killed the cat”: cats poisoned by alphachloralose containing rodenticides
  Marieke A Dijkman, Dutch Poisons Information Center (DPIC), University Medical Center Utrecht, Utrecht, Netherlands.
  Veterinary toxicology (poisoning in animals)
  
  385  A case series of hypothermic, sedated cats with sensory-induced CNS excitation: alphachloralose poisoning?
  Marieke A Dijkman, Dutch Poisons Information Center (DPIC), University Medical Center Utrecht, Utrecht, Netherlands.
  Veterinary toxicology (poisoning in animals)
  
  386 When does xylitol-induced hypoglycaemia occur in dogs?
  Nick Edwards, Veterinary Poisons Information Service, London, United Kingdom.
  Veterinary toxicology (poisoning in animals)
  
  387 The effect of the COVID-19 pandemic on call numbers to the Veterinary Poisons Information Service (VPIS) and Animal PoisonLine (APL)
  Nick Edwards, Veterinary Poisons Information Service, London, United Kingdom.
  Veterinary toxicology (poisoning in animals)
  
  388 The effect of the COVID-19 pandemic on animal poisons cases reported to the Veterinary Poisons Information Service (VPIS) and Animal PoisonLine (APL)
  Nick Edwards, Veterinary Poisons Information Service, London, United Kingdom.
  Veterinary toxicology (poisoning in animals)
  
  389 The successful treatment of thallium sulfate toxicity in a dog using Prussian blue
  Anne Kan, Dutch Poisons Information Center, University Medical Center, Utrecht, Netherlands.
  Veterinary toxicology (poisoning in animals)
  
  
• Lunchtime Posters - Room 05
  005  Is lithium exposure responsible for brain injuries with prolonged treatment or? A rat investigation
  Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
  Mechanisms of Toxicity and Basic Research
  
  009 Flurbiprofen toxicosis in dogs
  Nicola Bates, Veterinary Poisons Information Service, London, United Kingdom.
  Epidemiology of poisoning
  
  010 An analysis of cases of methaemoglobinaemia reported in telephone enquiries to the UK’s National Poisons Information Service (NPIS)
  Victoria A Eagling, NPIS Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
  Epidemiology of poisoning
  
  017   Drug-induced death in the intensive care unit in France: what are the characteristics?
  Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
  Epidemiology of poisoning
  
  023  Review of drug poisoning assessment at Emergency Department
  Marieke A Dijkman, Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
  Epidemiology of poisoning
  
  100  Poisoning in adolescents
  Patricia Casey, National Poisons Information Centre of Ireland, Dublin, Ireland.
  Epidemiology of poisoning
  
  115 The ICU Requirement Score (IRS) - does it identify poisoned patients who do not need intensive care unit referral? A validation cohort study
  Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
  VEpidemiology of poisoning
  
  344  Comparison of acute kidney injury and renal replacement therapy in patients with rhabdomyolysis acutely intoxicated with psychotropic or chemical substances
  Aleksandra Babulovska, Toxicology, University Clinic of Toxicology, Skopje, Macedonia.
  (only available on May 27th)
  Epidemiology of poisoning
  
  345 Increasing enquiries to the Norwegian Poison Information Center (NPIC) concerning ozone
  Marte S Evje, Norwegian Institute of Public Health, Norwegian Poison Information Centre, Oslo, Norway.
  Epidemiology of poisoning
  
  346 A 10-year review of ocular exposures reported to the Irish National Poisons Information Centre
  Conor P Malone, National Health Library and Knowledge Service, HSE, Dublin, Ireland.
  Epidemiology of poisoning
  
  347 Fatalities due to acute poisoning: a one year retrospective study
  Julia V Radenkova - Saeva, Clinic of Toxicology, University Hospital for Emergency Medicine „ N.I.Pirogov”, Sofia, Bulgaria.
  Epidemiology of poisoning
  
  
• Lunchtime Posters - Room 06
  071   A 16 year (2002-2017) review of enquiries regarding plant abuse in Austria
  Susanna Dorner-Schulmeister, Poisons Information Centre Austria, Vienna, Austria.
  Plant and Mushroom Poisoning
  
  072  A 16-year (2002-2017) review of suicide attempts by plant ingestion in Austria
  Susanna Dorner-Schulmeister, Poisons Information Centre Austria, Vienna, Austria.
  Plant and Mushroom Poisoning
  
  091  Mistaking monkshood for radish resulting in a potentially fatal blood concentration of aconitine
  Uwe Stedtler, Faculty of Medicine, Medical Centre, University of Freiburg, Freiburg, Germany.
  Plant and Mushroom Poisoning
  
  092   Intoxication with castor beans
  Marine Grigoryan, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
  Plant and Mushroom Poisoning
  
  112  Mushroom poisonings in Finland: a 15-year retrospective study
  Anne Tähkäpää, Poison Information Center, University of Helsinki and Department of Emergency Medicine and Services, Helsinki, Finland.
  Epidemiology of poisoning
  
  349  Lethal poisoning with Oenanthe crocata. Survive or not?
  Marieke A Dijkman, Alexis Descatha, PCC, Ester Unit (IRSET U1085), Univ Angers- CHU Angers- Inserm, Angers, France.
  Plant and Mushroom Poisoning
  
  
• Lunchtime Posters - Room 07
  219  Clozapine-induced anemia: a case report
  Andrea Giampreti, Emergency care, Poison Control Center, Bergamo, Italy.
  Adverse reactions from medications
  
  220 Lacosamide-induced recurrent ventricular fibrillation
  Andrea Giampreti, Emergency care, Poison Control Center, Bergamo, Italy.
  Adverse reactions from medications
  
  222 Bleeding events due to warfarin therapy: how much does it cost?
  Gabija Laubner, Toxicology Centre, Republican Vilnius University Hospital, Centre of Toxicology, Vilnius, Lithuania.
  Adverse reactions from medications
  
  223   Phenytoin intoxication associated with omeprazole administration in a child with CYP2C9 polymorphism
  Marco Marano, Emergency Department PICU. Regional Pediatric Poison Control Center., Bambino Gesù Children Hospital, Rome, Italy.
  Adverse reactions from medications
  
  226   Olanzapine overdose-induced agranulocytosis
  Gordana Vukovic Ercegovic, Department of Clinical Toxicology, National Poison Control Center, Military Medical Academy, Belgrade, Serbia.
  (only available on May 27th)
  Adverse reactions from medications
  
  227   From kitchen to clinical use, to emergency department admission: an Italian story about curcumin
  Francesco Gambassi, Toxicology Unit, Poison Control Center of Careggi University Hospital, Florence, Italy.
  Adverse reactions from medications
  
  229  Bowel perforation due to methotrexate therapeutic error: a case report.
  Francesco Gambassi, Marco Cirronis, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
  Adverse reactions from medications
  
  390  Pharmacovigilance for identification and prevention of therapeutic errors
  Anna Celentano, Milan Poison Control Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  Adverse reactions from medications
  
  391  Lamotrigine-induced Stevens-Johnson syndrome: a case report
  Andrea Giampreti, Emergency Department, Poison Control Center, Bergamo, Italy.
  Adverse reactions from medications
  
  392  Dimethyl fumarate-induced hepatotoxicity confirmed by biopsy
  Ophir Lavon, Clinical Pharmacology and Toxicology Unit, Carmel Medical Center, Haifa, Israel.
  Adverse reactions from medications
  
  
• Lunchtime Posters - Room 08
  001   Effect of ethanol coingestion in patients with central nervous system (CNS)-depressant intoxication
  Eva-Carina Heier, Division of Clinical Toxicology and Poison Control Centre Munich, Department of Internal Medicine II, TUM School of Medicine, Technical University of Munich, Munich, Germany.
  Alcohol as a co-ingestant
  
  031  Adults admitted to the emergency department of a university hospital in Belgium for acute poisoning with ethanol as a co-ingestant: characteristics and direct medical costs
  Anne-Marie K Descamps, Belgian Poison Centre, Brussels, Belgium.
  Alcohol as a co-ingestant
  
  175 EXP3OP study: occupational eye exposures reported to a western France poison center
  Gaël Le Roux, Centre antipoison et Toxicovigilance Grand Ouest, CHU d'Angers, Angers, France.
  Occupational poisoning
  
  399  Severe gasoline poisoning and its treatment. The autonomy of the lung response facing different pathogenic agents
  Ana Ferrer-Dufol, Unit of Clinical Toxicology, Clinical University Hospital, Zaragoza, Spain.
  Occupational poisoning
  
  400  The health and blood aluminium concentration in firefighters following the Alytus tyre recycling factory fire
  Gabija Laubner, Toxicology center, Republic Vilnius university hospital, Vilnius, Lithuania.
  Occupational poisoning
  
  401  A case of acute occupational exposure to sodium molybdate with determination of molybdenum concentration
  Azzurra Schicchi, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
  Occupational poisoning
  
  
• Lunchtime Posters - Room 09
  178  The role of CYP450 in the molecular toxicology of sulfur mustard in vitro
  Presented By Simone Rothmiller, Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany.
  Miscellaneous
  
  181  “All right, I’ll be more careful next time”: frequent callers in Finnish Poison Information Centre (FPIC)
  Suvi Pajarre-Sorsa, Poison Information Centre, Poison Information Centre, University of Helsinki and Department of Emergency Medicine and Services, Helsinki University Hospital, Helsinki, Finland, Helsinki, Finland.
  Miscellaneous
  
  184  Risky dietary supplements: self-harm with potassium salt capsules
  Sonny Larsson, Swedish Poison Information Centre, Solna, Sweden.
  Miscellaneous
  
  188  Supporting the establishment of an Ethiopian Poisons Centre
  Ruben Thanacoody, National Poisons Information Service (Newcastle Unit), Newcastle Hospitals NHS Foundation Trust, Newcastle, United Kingdom.
  Miscellaneous
  
  192  Diphtheria: two cases treated with antitoxin
  Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
  Miscellaneous
  
  363   Requests regarding snus to the Poisons Information Centre in Austria
  Tara Arif, Poisons Information Centre, Vienna, Austria.
  Miscellaneous
  
  364   Multiple treatments of clotrimazole during pregnancy
  Sian C D Harbon, National Poisons Information Service, Cardiff, United Kingdom.
  Miscellaneous
  
  365 Challenges facing the UK National Poisons Information Service (NPIS) ahead of EU Exit and commencement of Annex VIII of Article 45 (Classification, Labelling and Packaging)
  Pardeep S Jagpal, National Poisons Information Service (Birmingham Unit), Birmingham, United Kingdom.
  Miscellaneous
  
  366   When volvulus hides a poisoning: a case of severe foodborne botulism
  Roberto Zoppellari, Department of Anaesthesia and Intensive Care, S. Anna Hospital, Ferrara, Italy.
  Miscellaneous
  
  

CLOSE

REST BREAK AND AUTHORS WITH POSTERS(AFTERNOON GROUPING)

• AFTERNOON Posters - Room 01
  109   Non-medical use and injection use of prescription opioids in Europe in the Non-Medical Use of Prescription Drug (NMURx) National Surveys
  Janetta L Iwanicki, Rocky Mountain Poison and Drug Safety, Denver, United States.
  Drugs of abuse and NPS poisoning
  
  118 Drug abuse trends, focussing on novel psychoactive substances (NPS) over the last three years (2016-2018) from the perspective of the Austrian Poisons Information Centre
  Kinga Bartecka-Mino, Poisons Information Centre Austria, Vienna, Austria.
  Drugs of abuse and NPS poisoning
  
  122  A retrospective study of observation times in a healthcare facility and 48-hour mortality after heroin overdose with naloxone rescue
  William Rushton, Office of Medical Toxicology, Department of Emergency Medicine, University of Alabama at Birmingham, Birmingham, United States.
  Drugs of abuse and NPS poisoning
  
  127  Analysis of Twitter content to explore use of modafinil and methylphenidate as drugs to facilitate studying in the UK
  David Wood, Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  Drugs of abuse and NPS poisoning
  
  128  Non-medical use of prescription and over the counter opioids in the UK
  David Wood, Clinical Toxicology, Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom.
  Drugs of abuse and NPS poisoning
  
  140  Significant cannabidiol (CBD) urine concentration in a young male admitted after using an e-cigarette obtained from a street market
  Alison M Dines, Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London, United Kingdom.
  Drugs of abuse and NPS poisoning
  
  145  Mining and analysis of opioid content in longitudinal data posted in a social media forum
  Jeanmarie Perrone, Emergency Medicine, University of Pennsylvania, Philadelphia, United States.
  (only available on May 28th)
  Drugs of abuse and NPS poisoning
  
  156  Hydroxyphencyclidines (OH-PCPs), fluoroamphetamine (FA) and fluoromethamphetamine (FMA): an explosive NPS mixture and a challenge for appropriate sedation in a severely intoxicated patient patient.
  Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
  Drugs of abuse and NPS poisoning
  
  326  Acute recreational drug toxicity in Ghent, Belgium. Comparison of self-reports and analytical detection by immunoassay (IA) and mass spectrometry (MS) testing
  Laurence Daveloose, Emergency medicine, UZ Ghent, Ghent, Belgium.
  Drugs of abuse and NPS poisoning
  
  327  In vino veritas: accidental MDMA poisoning by illicit drug trafficking
  Katrin Faber, National Poisons Information Centre, Associated Institute of the University of Zurich, Zurich, Switzerland.
  Drugs of abuse and NPS poisoning
  
  328  Frequent hospitalization for synthetic cathinone poisonings: a case series reported to the Dutch Poisons Information Center
  Johanna J Nugteren-Van Lonkhuyzen, Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht, Netherlands.
  Drugs of abuse and NPS poisoning
  
  329  Exposures involving opioids and alcohol reported to the US Poison Centers
  Saumitra Rege, Department of Emergency Medicine, University of Virginia, Charlottesville, United States.
  Drugs of abuse and NPS poisoning
  
  330  The Color Purple: death associated with brorphine, an emerging novel synthetic opioid
  Varun Vohra, Emergency Medicine, Michigan Poison Center, Wayne State University School of Medicine, Detroit, United States.
  Drugs of abuse and NPS poisoning
  
  
• AFTERNOON Posters - Room 02
  402  Acute poisoning in Moscow during COVID-19 restrictive measures
  Anastasia Yu Simonova, Toxicological department, N.V. Sklifosovsky’ Research Institute of Emergency Medicine, Moscow, Russian Federation.
  Covid-19 and toxicology
  
  403 Unintended consequences of public health measures: exposures to alcohol-based hand sanitisers during the COVID-19 pandemic 2020
  Patricia Casey, National Poisons Information Centre of Ireland, Dublin, Ireland.
  Covid-19 and toxicology
  
  404  Increased exposures to alcohol-based hand sanitizers reported by an Italian Poison Center during the COVID-19 pandemic
  Anna Celentano, Milan Poison Control Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  Covid-19 and toxicology
  
  405  Pediatric eye injuries related to public location of alcohol-based hand sanitizers during the first pandemic COVID-19 context: French Poison Control Centers data
  Alexis Descatha, PCC, Ester Unit (IRSET U1085), UNIV Angers, CHU Angers, Univ Rennes, Inserm, EHESP, Irset,, Angers, France.
  Covid-19 and toxicology
  
  406  Has the COVID-19 pandemic changed the pattern of poisoning cases attending Emergency Departments?
  Ana Ferrer-Dufol, Unit of Clinical Toxicology, Clinical University Hospital, Zaragoza, Spain.
  Covid-19 and toxicology
  
  407  The only thing we have to fear is fear itself: inadvertent disopyramide toxicity during the COVID-19 pandemic
  Emma R Furlano, Division of Medical Toxicology, Ronald O. Perelman Department of Emergency Medicine, NYU Grossman School of Medicine, New York, United States.
  Covid-19 and toxicology
  
  408  Nicotine does not affect SARS-CoV-2 in-host viral kinetics in a modeling and simulation study
  Charlotte Kern, Department of General Internal Medicine, Clinical Pharmacology and Toxicology, Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern; Graduate School for Health Sciences, University of Bern, Bern, Bern, Switzerland.
  Covid-19 and toxicology
  
  409  A human exposure to chlorine dioxide solution...not the solution
  Valle Molina, Emergencie, Complejo Hospitalario de Navarra, pamplona, Spain.
  Covid-19 and toxicology
  
  410  Changes in the epidemiological profile of poisonings during COVID-19: differences between the first half of 2019 and 2020
  Zanina Pereska, University Clinic of Toxicology, Skopje, Macedonia.
  (only available on May 27th)
  Covid-19 and toxicology
  
  411  Multiple factors in a COVID-19 patient leading to an elevated 5-oxoproline as cause of high-anion gap metabolic acidosis: a case report
  Marian Piqueur, Departement of Laboratory Medicine, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
  Covid-19 and toxicology
  
  
• AFTERNOON Posters - Room 03
  200  Efficacy of a 12h intravenous acetylcysteine (SNAP) regimen following single acute paracetamol overdose
  Ruben HK Thanacoody, National Poisons Information Service (Newcastle), Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  Pharmaceutical Poisoning
  
  239 Torsade de pointes following repeated massive loperamide ingestion
  Aza Kader, Swedish Poisons Information Centre, Stockholm, Sweden.
  Covid-19 and toxicology
  
  247  Using “symptom search” to resolve an unusual case of poisoning reported to the UK National Poisons Information Service (NPIS)
  Ho MR Lee, NPIS (Birmingham Unit), City Hospital, Birmingham, United Kingdom.
  Pharmaceutical Poisoning
  
  249  Different courses of quetiapine poisoning in two patients with gastric decontamination
  Anne Stuerzebecher, Poisons Information Centre Erfurt, Erfurt, Germany.
  Pharmaceutical Poisoning
  
  261  Massive polypharmacy overdose resulting in diltiazem pharmacobezoar formation
  David Goldberger, Emergency Medicine, Albert Einstein Medical Center, Philadelphia, United States.
  Pharmaceutical Poisoning
  
  
• AFTERNOON Posters - Room 04
  232  General characteristics of acute poisonings by hypotensive and antiarrhythmic drugs in Moscow, 2010-2017
  Presented By Anastasia Yu Simonova, Moscow N.V.SklifosovskyResearch Institute of emergency medical Help, Poisonng teatment Center, Moscow, Russian Federation.
  Pharmaceutical Poisoning
  
  233 Acute toxicity profile of levomepromazine in overdose: a consecutive case series
  Stefan Weiler, National Poisons Centre, Tox Info Suisse, Associated Institute of the University of Zurich, Zurich, Switzerland.
  Pharmaceutical Poisoning
  
  234  Be(a)ware of the fentanyl patch: unusual accidental cases of fentanyl intoxication
  Marianne EC Leenders, National Poisons Information Center/Department of Anesthesiology, University Medical Center, Utrecht, Netherlands.
  Pharmaceutical Poisoning
  
  235  Calls to the Finnish Poison Information Centre related to drug poisoning in older people
  Mervi Saukkonen, Poison Information Center, University of Helsinki and Department of Emergency Medicine and Services, Helsinki University Hospital, Helsinki, Finland.
  Pharmaceutical Poisoning
  
  236  Preliminary experience with plasmapheresis instead of molecular adsorbent recirculating system as liver support for paracetamol-induced hepatic failure
  Philippe Hantson, Intensive Care, Cliniques St-Luc, Université catholique de Louvain, Brussels, Belgium.
  Pharmaceutical Poisoning
  
  237 Acute poisoning with antihypertensive drugs: a retrospective study
  Julia V Radenkova-Saeva, Clinic of Toxicology,, UMHATEM “N.I.Pirogov”, Sofia, Bulgaria.
  Pharmaceutical Poisoning
  
  238  Rectal overdose of paracetamol
  Johanna Nordmark Grass, Swedish Poisons Information Centre, Stockholm, Sweden.
  Pharmaceutical Poisoning
  
  248  Favorable toxicity profile of escitalopram in acute overdose in adults
  Katharina M Schenk-Jaeger, National Poisons Information Centre, Tox Info Suisse, Associated Institute of the University of Zurich, Zurich, Switzerland.
  Pharmaceutical Poisoning
  
  250  The association between phenytoin (diphenylhydantoin) and permanent cerebellar damage
  Rachel Day, National Poisons Information Service, Birmingham Centre, Birmingham, United Kingdom.
  Pharmaceutical Poisoning
  
  343  Literature review of antidotal carbapenem use in valproic acid toxicity
  William Rushton, Alabama Poison Information Center, Children's of Alabama, Birmingham, United States.
  Pharmaceutical Poisoning
  
  
• AFTERNOON Posters - Room 05
  103 Mass acute thallium poisoning treated with enteral detoxification using Prussian blue and gut lavage
  Anastasyja Yu Simonova, N.V.Sklifosovsky Rtesearch Institute of Emergency Medicine, Poisonings Treatment Department, Moscow, Russian Federation..
  Heavy Metal Poisoning
  
  162 Arsenic exposure and peripheral neuropathy
  Chay J Markham, Cardiff University, Cardiff, United Kingdom.
  Heavy Metal Poisoning
  
  163 Gadolinum contrast media: old substance, new challenges
  Gabija Mikuleviciene, Toxicology Centre, Republican Vilnius University Hospital, Centre of Toxicology, Vilnius, Lithuania
  Heavy Metal Poisoning
  
  165 Comparison of unithiol (DMPS) treatment effect in two patients with severe cobalt intoxication
  Daniela Pelclova, Toxicological Information Centre, First Medical Faculty and General University Hospital, Prague, Czech Republic.
  Heavy Metal Poisoning
  
  168 Toxicokinetics of silver and chelation unithiol (DMPS) challenge tests in argyria due to colloidal silver
  Gasper Razinger, Centre for Clinical Toxicology and Pharmacology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  PHeavy Metal Poisoning
  
  412 An unsolved mystery: idiopathic thallium exposure resulting in clinically significant toxic effects
  Varun Vohra, Emergency Medicine, Michigan Poison Center at Wayne State University School of Medicine, Detroit, United States.
  Heavy Metal Poisoning
  
  
  
• AFTERNOON Posters - Room 06
  070  Suicidal Cerbera odollam poisoning: a case report
  Angelika Holzer, Poisons Information Centre Austria, Vienna, Austria.
  Plant and Mushroom Poisoning
  
  081 A severe and prolonged case of Amanita phalloides poisoning
  Anja J Huusom, Department of Occupational and Environmental Medicine, The Danish Poisons Information Centre, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark.
  Plant and Mushroom Poisoning
  
  085  Facial paralysis after cutaneous burns from Heracleum mantegazzianum
  Azzurra Schicchi, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
  Plant and Mushroom Poisoning
  
  088  Does combining vitamin C and vitamin B17 (amygdalin) worsen toxicity?
  Faisal S Minhaj, Maryland Poison Center, Baltimore, United States.
  Plant and Mushroom Poisoning
  
  089  Confusion between toxic and edible plants registered by the French Poison Control Centres from 2012 to 2018
  Sandra Sinno-Tellier, Health Alerts and Vigilance department, French Agency for Food, Environmental and Occupational Health & Safety, MAISONS-ALFORT, France.
  Plant and Mushroom Poisoning
  
  090 Acute poisoning due to Datura ingestion: case report
  Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
  Plant and Mushroom Poisoning
  
  093  Severe plant poisonings admitted to the intensive care in France: management and outcome
  Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
  Plant and Mushroom Poisoning
  
  105  Toxicological evaluation of a cluster of reports of hepatitis related to turmeric dietary supplements in Italy
  Azzurra Schicchi, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
  Miscellaneous
  
  350 The White Panther: rare exposure to Amanita multisquamosa causing clinically significant toxicity
  Varun Vohra, Emergency Medicine, Michigan Poison Center, Wayne State University School of Medicine, Detroit, United States.
  Plant and Mushroom Poisoning
  
  
• AFTERNOON Posters - Room 07
  008  Portal embolism in hydrogen peroxide ingestion: a case series
  Marco Cirronis, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
  Household Products Poisoning
  
  051 Artificial nail primer: a case series from Pavia Poison Control Centre
  Carlo A Locatelli, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
  Household Products Poisoning
  
  052 Nail glue: a beauty hazard
  Carlo A Locatelli, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia (Italy), Pavia, Italy.
  Household Products Poisoning
  
  353  Accidental exposures to caustic drain cleaners
  Anna Celentano, Milan Poison Control Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  Household Products Poisoning
  
  354  The “lactate gap” as a useful tool to detect ethylene glycol intoxications
  Dieter Geysels, Department of Laboratory Medicine, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
  Household Products Poisoning
  
  355 A one-year review of enquiries to the UK National Poisons Information Service involving cosmetic products
  Emma J Moyns, National Poisons Information Service (Birmingham Unit), Birmingham, United Kingdom.
  Household Products Poisoning
  
  356  Acute ethylene glycol poisoning: a one year epidemiological study
  Julia V Radenkova - Saeva, Clinic of Toxicology, University Hospital for Emergency Medicine „ N.I.Pirogov”,, Sofia, Bulgaria.
  Household Products Poisoning
  
  357  Button battery ingestion: experience of the UK National Poisons Information Service (NPIS)
  Simon H L Thomas, National Poisons Information Service (Newcastle Unit), Regional Drugs and Therapeutics Centre, Newcastle upon Tyne, United Kingdom.
  Household Products Poisoning
  
  
• AFTERNOON Posters - Room 08
  035  Amitraz: an unfamiliar insecticide with familiar toxicity
  William Rushton, Office of Medical Toxicology, University of Alabama at Birmingham, Birmingham, United States.
  Pesticide Poisoning
  
  040 The impact of obidoxime on duration of hospitalization in acute organophosphate poisoning in Muratsan University Hospital, Yerevan, Armenia, 2012-2019
  Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
  Pesticide Poisoning
  
  041 Poisoning risk of acute exposures to repellents: results from a prospective observational study
  Maren Hermanns-Clausen, Poisons Information Centre, Department of Pediatrics and Adolescent Medicine, Faculty of Medicine, Medical Center – University of Freiburg, Freiburg, Germany.
  Pesticide Poisoning
  
  043  Organophosphate poisoning among children and adolescents in Armenia: a retrospective case study
  Marine Grigoryan, Toxicology and Pediatric Intensive Care Unit, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia.
  Pesticide Poisoning
  
  044  Lethal intoxication by pentachlorophenol
  Francesca Maida, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
  Pesticide Poisoning
  
  360 Evaluation of biocidal product enquiries to the Austrian Poisons Information Centre, 2017
  Tara Arif, Poisons Information Centre, Vienna, Austria.
  Pesticide Poisoning
  
  
• AFTERNOON Posters - Room 09
  224  Two case of opioid withdrawal syndrome precipitated by alcohol dependence treatment with nalmefene successfully treated with morphine
  Jonas Moens, Belgian Poison Centre, Brussels, Belgium.
  Adverse reactions from medications
  
  228 Accidental injection of pseudorabies pigs vaccine in humans
  Azzurra Schicchi, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
  Adverse reactions from medications
  
  393 Iodoform medications may cause iodine toxicosis: two case reports
  Marco Cirronis, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
  Adverse reactions from medications
  
  394  Fooled by adrenaline: a pyrogenic-like reaction during treatment of a common European viper bite
  Anton Gustafsson, Swedish Poisons Information Center, Swedish Poisons Information Center, Stockholm, Sweden.
  Adverse reactions from medications
  
  395  Symptomatic therapeutic errors in the elderly: a case study
  Carlo A Locatelli, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
  Adverse reactions from medications
  
  396 Severe adverse effects after a second dose of paliperidone palmitate long-acting injectable administration: a case report
  Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
  Adverse reactions from medications
  
  397  Soft capsules formulated with ethanol: unexpected disulfiram-ethanol reaction after one dosage of ciclosporin
  Jonas Moens,Belgian Poison Control Centre, NEDER-OVER-HEEMBEEK, Belgium.
  Adverse reactions from medications
  
  398 Effect of a 12-hour intravenous acetylcysteine (SNAP) regimen on the International Normalized Ratio (INR)
  Ruben Thanacoody, Newcastle University, Newcastle Upon Tyne, United Kingdom.
  Adverse reactions from medications
  
  
• AFTERNOON Posters - Room 10
  058  Sticky eye: a pediatric case of cyanoacrylate ocular exposure
  Presented By Davide Lonati, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Spain.
  Paediatric Poisoning
  
  063 Pediatric cannabis poisonings in France: more and more frequent and severe.
  Gaël Le Roux, >Centre antipoison et Toxicovigilance Grand Ouest, CHU d'Angers, Angers, France.
  Paediatric Poisoning
  
  371 Childhood poisonings: five-years’ experience from an Italian pediatric emergency department
  Andrea Giampreti, Bergamo Poison Control Center, ASST Papa Giovanni XXIII, Bergamo, Italy.
  Paediatric Poisoning
  
  372  Fooled by adrenaline: a pyrogenic-like reaction during treatment of a common European viper bite
  Anton Gustafsson, Swedish Poisons Information Center, Swedish Poisons Information Center, Stockholm, Sweden.
  Adverse reactions from medications
  
  373  Altered mental status following a large ondansetron ingestion in a toddler
  Vincent Calleo, Emergency Medicine, SUNY Upstate Medical University, Syracuse, United States.
  Paediatric Poisoning
  
  374 Severe salicylic acid intoxication with a topical skin preparation in a newborn
  Andrea Giampreti, Bergamo Poison Control Center, Bergamo Poison Control Center, Bergamo, Italy.
  Paediatric Poisoning
  
  375  38 Weeks pregnant: managing a mother and neonate after a third-trimester acetaminophen ingestion
  Charlotte Goldfine, Emergency Medicine, Brigham and Women's Hospital, Boston, United States.
  Paediatric Poisoning
  
  376 Epidemiology of pediatric benzodiazepines exposures using the National Poison Data System
  Saumitra Rege, Department of Emergency Medicine, University of Virginia, Charlottesville, United States.
  Paediatric Poisoning
  
  
• AFTERNOON Posters - Room 11
  104  Long-term exposure to Sargassum-seaweed pollution in the French Caribbean Islands: clinical consequences and outcome
  Dabor Resiere, Critical Care Medicine, University Hospital of Martinique, Fort de France, Martinique.
  Epidemiology of poisoning
  
  284 Latrodectus tredecemguttatus poisoning: a case report treated with antidote
  Marco Cirronis, Pavia Poison Control Centre - National Toxicology Information Centre - Clinical and Experimental Lab, Toxicology Unit, Maugeri Clinical and Scientific Institutes IRCCS and University of Pavia, Pavia, Italy.
  Toxinology (bites, stings, antivenom etc)
  
  285 Prolonged neurological effects after delayed antivenin administration
  Alfred Aleguas, Poison Information Center-Tampa, Tampa General Hospital, Tampa, United States.
  Toxinology (bites, stings, antivenom etc)
  
  286  Cardiovascular complications following ciguatera fish poisoning in the French West Indies: a case series
  Dabor Resiere, Critical Care Medicine, University Hospital of Martinique, Fort de France, Martinique.
  Toxinology (bites, stings, antivenom etc)
  
  287  Epidemiology of bites by indigenous venomous snakes in Switzerland reported to Tox Info Suisse over a 22 year period
  Joan Fuchs, Swiss National Poisons Information Center, Tox Info Suisse, Associated Institute of the University of Zurich, Zurich, Switzerland.
  Toxinology (bites, stings, antivenom etc)
  
  289 An analysis of envenoming features in adder bite cases referred to the UK National Poisons Information Service (NPIS)
  David Stewart, NPIS Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
  Toxinology (bites, stings, antivenom etc)
  
  290  Kambô: a healing potion or a poisonous toxin?
  Annie Watt, NPIS Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
  Toxinology (bites, stings, antivenom etc)
  
  291 Viper bite neurotoxicity: two pediatric cases in central Italy
  Marco Marano, Emergency Department PICU. Regional Pediatric Poison Control Center., Bambino Gesù Children Hospital, Rome, Italy.
  Toxinology (bites, stings, antivenom etc)
  
  292 Thromboelastogram use in Crotalus adamanteus envenomation
  William F Rushton, Office of Medical Toxicology, Department of Emergency Medicine, University of Alabama at Birmingham, Birmingham, United States.
  Toxinology (bites, stings, antivenom etc)
  
  381 Rattlesnake bite in Austria: a case report
  Susanna Dorner-Schulmeister, Poisons Information Centre, Vienna, Austria.
  Toxinology (bites, stings, antivenom etc)
  
  382 Bitten abroad, an unforgettable souvenir: bites and stings reported to the UK National Poisons Information Service (NPIS) sustained whilst travelling overseas, 2009-2019
  Pardeep S Jagpal, National Poisons Information Service (Birmingham Unit), Birmingham, United Kingdom.
  Toxinology (bites, stings, antivenom etc)
  
  
• AFTERNOON Posters - Room 12
  185  Valproic acid in the management of delirious, agitated critically ill toxicology patients
  Joseph J Rasimas, Consultation - Liaison Psychiatry, Hennepin County Medical Center, Minneapolis, United States.
  Miscellaneous
  
  186 Takotsubo syndrome during benzodiazepine withdrawal: a case report
  Francesco Gambassi, Medical Toxicology Unit and Poison Control Center, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy.
  Miscellaneous
  
  191 Myocardial infarction in the acutely poisoned patient: a case series
  Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
  Miscellaneous
  
  193  QTc interval and electrolyte derangement in alcohol withdrawal-related seizures
  Agnesa Mustafa, Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  Miscellaneous
  
  203   Emergent toxicological molecular screening test on ICU admission: can it be trusted?
  Bruno Mégarbane, Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS-1144, Paris, France.
  Analytical and Forensic Toxicology - including bedside testing
  
  211 The value of post-mortem toxicology in deciding whether a death is drug-induced
  James M Coulson, Clinical Pharmacology, Cardiff University, Cardiff, United Kingdom.
  Analytical and Forensic Toxicology - including bedside testing
  
  216  Laboratory practice variations complicate poison centre recommendations for massive paracetamol overdose
  Timothy C Backus, NYU School of Medicine, New York, United States.
  Analytical and Forensic Toxicology - including bedside testing
  
  218 Poison center recommendations for methylxanthine toxicity may be complicated by limited access to theophylline measurements
  Timothy C Backus, NYU School of Medicine, New York, United States.
  Analytical and Forensic Toxicology - including bedside testing
  
  361 Biological sample collection in the emergency department and laboratory substance abuse investigation and confirmation: a methamphetamine case report
  Anna Celentano, Milan Poison Control Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  Analytical and Forensic Toxicology - including bedside testing
  
  362 Post-mortem ethanol concentrations
  James M Coulson, All Wales Therapeutics & Toxicology Centre, Cardiff University, Cardiff, United Kingdom.
  Analytical and Forensic Toxicology - including bedside testing
  
  

CLOSE